103,239 Shares in Aurora Cannabis Inc. $ACB Acquired by Northwest & Ethical Investments L.P.

Key Points

• Northwest & Ethical Investments L.P. purchased 103,239 shares of Aurora Cannabis, valued at approximately $452,000, increasing its ownership to 0.18% of the company.
• Aurora Cannabis announced a quarterly loss of ($0.19) EPS, missing expectations, with revenues of $71.98 million, below analyst estimates of $96.83 million.
• Analysts show mixed ratings for Aurora Cannabis, with Zacks Research updating it to a "strong sell" and a general consensus rating of "Buy" among several analysts.

Northwest & Ethical Investments L.P. purchased a new stake in Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 103,239 shares of the company's stock, valued at approximately $452,000. Northwest & Ethical Investments L.P. owned about 0.18% of Aurora Cannabis as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Renaissance Technologies LLC boosted its holdings in Aurora Cannabis by 8.6% in the fourth quarter. Renaissance Technologies LLC now owns 714,655 shares of the company's stock valued at $3,037,000 after purchasing an additional 56,400 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Aurora Cannabis by 7.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 84,921 shares of the company's stock valued at $361,000 after purchasing an additional 5,800 shares during the last quarter. Connective Capital Management LLC purchased a new position in Aurora Cannabis in the fourth quarter valued at about $330,000. Two Sigma Advisers LP boosted its holdings in Aurora Cannabis by 18.7% in the fourth quarter. Two Sigma Advisers LP now owns 62,100 shares of the company's stock valued at $264,000 after purchasing an additional 9,793 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in Aurora Cannabis by 4.0% in the first quarter. TD Asset Management Inc now owns 60,949 shares of the company's stock valued at $267,000 after purchasing an additional 2,321 shares during the last quarter. Hedge funds and other institutional investors own 47.63% of the company's stock.

Analysts Set New Price Targets

ACB has been the subject of a number of analyst reports. Zacks Research raised Aurora Cannabis to a "strong sell" rating in a report on Friday, August 8th. Wall Street Zen cut Aurora Cannabis from a "hold" rating to a "sell" rating in a research note on Friday, July 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Aurora Cannabis currently has a consensus rating of "Buy".

Aurora Cannabis Stock Performance

Shares of Aurora Cannabis stock traded up $0.24 on Monday, reaching $5.23. 2,516,983 shares of the company were exchanged, compared to its average volume of 1,857,364. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.51 and a current ratio of 2.97. The company's 50-day moving average is $4.64 and its two-hundred day moving average is $4.86. The firm has a market cap of $295.23 million, a price-to-earnings ratio of -27.53 and a beta of 1.84. Aurora Cannabis Inc. has a 1-year low of $3.42 and a 1-year high of $6.91.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.37). The company had revenue of $71.98 million for the quarter, compared to analyst estimates of $96.83 million. Aurora Cannabis had a negative return on equity of 1.49% and a negative net margin of 5.66%. As a group, research analysts expect that Aurora Cannabis Inc. will post 0.46 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.